KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Other Non Operating Income: 2013-2015

Historic Other Non Operating Income for Teva Pharmaceutical Industries (TEVA) over the last 1 years, with Dec 2015 value amounting to $600,000.

  • Teva Pharmaceutical Industries' Other Non Operating Income rose 101.36% to $600,000 in Q4 2015 from the same period last year, while for Dec 2015 it was -$27.4 million, marking a year-over-year increase of 8.67%. This contributed to the annual value of -$65.0 million for FY2017, which is 232.65% down from last year.
  • According to the latest figures from Q4 2015, Teva Pharmaceutical Industries' Other Non Operating Income is $600,000, which was up 101.36% from -$44.2 million recorded in Q4 2014.
  • Teva Pharmaceutical Industries' Other Non Operating Income's 5-year high stood at $32.0 million during Q2 2013, with a 5-year trough of -$44.2 million in Q4 2014.
  • Its 3-year average for Other Non Operating Income is $657,143, with a median of $2.0 million in 2013.
  • In the last 5 years, Teva Pharmaceutical Industries' Other Non Operating Income tumbled by 200.00% in 2014 and then skyrocketed by 101.36% in 2015.
  • Quarterly analysis of 3 years shows Teva Pharmaceutical Industries' Other Non Operating Income stood at $32.0 million in 2013, then slumped by 71.88% to -$44.2 million in 2014, then spiked by 101.36% to $600,000 in 2015.
  • Its Other Non Operating Income was $600,000 in Q4 2015, compared to -$44.2 million in Q4 2014 and $7.2 million in Q3 2014.